logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Early breast cancer, DCIS: no higher induration rates with hypofractionated RT in DBCG HYPO

No worse outcomes, including locoregional recurrence or OS, with hypo- vs standard fractionated RT.